Correction: treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice

by LaClair, Katherine D, Manaye, Kebreten F, Lee, Dexter L, Allard, Joanne S, Savonenko, Alena V, Troncoso, Juan C, Wong, Philip C
Published 2013

Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice

by LaClair, Katherine D, Manaye, Kebreten F, Lee, Dexter L, Allard, Joanne S, Savonenko, Alena V, Troncoso, Juan C, Wong, Philip C
Published 2013

Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease

by Jankowsky, Joanna L, Slunt, Hilda H, Gonzales, Victoria, Savonenko, Alena V, Wen, Jason C, Jenkins, Nancy A, Copeland, Neal G, Younkin, Linda H, Lester, Henry A, Younkin, Steven G, Borchelt, David R
Published 2005

Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation

by Savonenko, Alena V., Melnikova, Tatiana, Wang, Yuchuan, Ravert, Hayden, Gao, Yongjun, Koppel, Jeremy, Lee, Deidre, Pletnikova, Olga, Cho, Eugenia, Sayyida, Nuzhat, Hiatt, Andrew, Troncoso, Juan, Davies, Peter, Dannals, Robert F., Pomper, Martin G., Horti, Andrew G.
Published 2015